Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.News:Easy to change the world: shareholders intend to reduce their holdings by no more than 3.05% in total;
Second, Contemporary Amperex Technology Co., Limited's enlargement trick: special dividends for factories in EuropeIn addition, it is planned to distribute a cash dividend of 12.3 yuan to all shareholders for every 10 shares, with a total dividend of 4.5 billion yuan. In April this year, Ningde has paid dividends of 22 billion yuan, and this time it totaled 27.4 billion yuan. According to the current market value of 11,900, the corresponding dividend yield is 2.3%! It's really not low.Easy to change the world: shareholders intend to reduce their holdings by no more than 3.05% in total;
Let's talk about some encouraging and unintelligent observations. Now the main purpose of everyone's smashing is to adjust positions, not to sell them back. This is the biggest difference from the past few years! Explain that regardless of retail investors, institutions and foreign investors, they still believe in the A-share bull market.First, heavy! Shanghai merger and reorganization action plan announcedContemporary Amperex Technology Co., Limited announced that the company plans to pay dividends with 15% of the net profit in the first three quarters of 2024, that is, 5.4 billion yuan as the total distribution, and distribute a cash dividend of 12.3 yuan to all shareholders for every 10 shares. In addition, Contemporary Amperex Technology Co., Limited and Stellantis plan to jointly set up a joint venture company in Spain, with each party holding 50% of the shares. The estimated total investment of the battery factory is 4.038 billion euros.
Strategy guide 12-13
Strategy guide
Strategy guide
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
Strategy guide 12-13
Strategy guide 12-13